BRCA1 and neoplasm: Mice studies suggested that the E3 ligase activity is not essential to prevent tumor development10, as the effects of patient-derived BRCA1 RING domain mutations such as C61G or C64G, which are required for tumor suppression and HR, are likely due to the disruption of the interaction of BRCA1 with BARD111.